Methylation mediated silencing of miR-23b expression and its role in glioma stem cells

Neuroscience Letters

Volumn 528, Issue 2, 2012, Pages 185-189

  Geng, Jiong ^a   Luo, Hui ^b   Pu, Yi ^a   Zhou, Zhimin ^a   Wu, Xiaoming ^c   Xu, Wenhui ^c   Yang, Zhengxiang ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c YIXING PEOPLE S HOSPITAL   (China)

Author keywords

Glioma; Glioma stem cells; Methylation; MicroRNA

Indexed keywords

AZACITIDINE; MICRORNA; MICRORNA 23B; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; GLIOMA CELL; GLIOMA STEM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; AZACITIDINE; BRAIN NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE SILENCING; GLIOMA; HUMANS; METHYLATION; MICRORNAS; NEOPLASTIC STEM CELLS; PROMOTER REGIONS, GENETIC;

EID: 84867695818     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.055     Document Type: Article

References (26)

1. Bertrand J., Begaud-Grimaud G., Bessette B., Verdier M., Battu S., Jauberteau M.O. Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. International Journal of Oncology 2009, 34:717-727.
2. Bomken S., Fiser K., Heidenreich O., Vormoor J. Understanding the cancer stem cell. British Journal of Cancer 2010, 103:439-445.
3. Bouchard J. Mechanism of action of 5-AZA-dC: induced DNA hypomethylation does not lead to aberrant gene expression in human leukemic CEM cells. Leukemia Research 1989, 13:715-722.
4. Datta J., Kutay H., Nasser M.W., Nuovo G.J., Wang B., Majumder S., Liu C.G., Volinia S., Croce C.M., Schmittgen T.D., Ghoshal K., Jacob S.T. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Research 2008, 68:5049-5058.
5. Denysenko T., Gennero L., Roos M.A., Melcarne A., Juenemann C., Faccani G., Morra I., Cavallo G., Reguzzi S., Pescarmona G., Ponzetto A. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell Biochemistry and Function 2010, 28:343-351.
6. Ehtesham M., Stevenson C.B., Thompson R.C. Stem cell therapies for malignant glioma. Neurosurgical Focus 2005, 19:E5.
7. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G., Pilozzi E., Larocca L.M., Peschle C., De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death and Differentiation 2006, 13:1238-1241.
8. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nature Reviews 2008, 9:102-114.
9. Ham O., Song B.W., Lee S.Y., Choi E., Cha M.J., Lee C.Y., Park J.H., Kim I.K., Chang W., Lim S., Lee C.H., Kim S., Jang Y., Hwang K.C. The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials 2012, 33:4500-4507.
10. He H.C., Zhu J.G., Chen X.B., Chen S.M., Han Z.D., Dai Q.S., Ling X.H., Fu X., Lin Z.Y., Deng Y.H., Qin G.Q., Cai C., Chen J.H., Zhong W.D. MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Letters 2012, 586:2451-2458.
11. Langevin S.M., Stone R.A., Bunker C.H., Grandis J.R., Sobol R.W., Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010, 31:864-870.
12. Loftus J.C., Ross J.T., Paquette K.M., Paulino V.M., Nasser S., Yang Z., Kloss J., Kim S., Berens M.E., Tran N.L. miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. PLoS One 2012, 7:e39818.
13. Lujambio A., Calin G.A., Villanueva A., Ropero S., Sanchez-Cespedes M., Blanco D., Montuenga L.M., Rossi S., Nicoloso M.S., Faller W.J., Gallagher W.M., Eccles S.A., Croce C.M., Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13556-13561.
14. Maslov A.Y., Lee M., Gundry M., Gravina S., Strogonova N., Tazearslan C., Bendebury A., Suh Y., Vijg J. 5-Aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Oncogene 2012, [Epub ahead of print]. 10.1016/j.neulet.2012.10.1038.
15. Momparler R.L. Pharmacology of 5-Aza-2'-deoxycytidine (decitabine). Seminars in Hematology 2005, 42:S9-S16.
16. Nishino J., Kim I., Chada K., Morrison S.J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 2008, 135:227-239.
17. Salvi A., Sabelli C., Moncini S., Venturin M., Arici B., Riva P., Portolani N., Giulini S.M., De Petro G., Barlati S. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. The FEBS Journal 2009, 276:2966-2982.
18. Singh K.P., Treas J., Tyagi T., Gao W. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Letters 2012, 316:62-69.
19. Sun L., Wu Z., Shao Y., Pu Y., Miu W., Yao J., Wu Y., Yang Z.X. MicroRNA-34a Suppresses Cell Proliferation and Induces Apoptosis in U87 Glioma Stem Cells. Technology in Cancer Research & Treatment 2012, 11:483-490.
20. Tong A.W., Fulgham P., Jay C., Chen P., Khalil I., Liu S., Senzer N., Eklund A.C., Han J., Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Therapy 2009, 16:206-216.
21. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., Tokino T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Research 2008, 68:4123-4132.
22. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:18255-18260.
23. Weber B., Stresemann C., Brueckner B., Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle (Georgetown, TX) 2007, 6:1001-1005.
24. Wong J.W. MicroRNA-induced silencing of glioma progression. The Journal of Neuroscience 2010, 30:3868-3869.
25. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., Liang S., Leminen A., Deng S., Smith L., Johnstone C.N., Chen X.M., Liu C.G., Huang Q., Katsaros D., Calin G.A., Weber B.L., Butzow R., Croce C.M., Coukos G., Zhang L. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research 2008, 68:10307-10314.
26. Zhang H., Hao Y., Yang J., Zhou Y., Li J., Yin S., Sun C., Ma M., Huang Y., Xi J.J. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nature Communications 2011, 2:554.